Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 250

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 7A
Chunk 250
---

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate   /s/ Lewis H. BenderPresident, Chief Executive Officer and ChairmanMarch 13, 2025Lewis H. Bender(principal executive officer) /s/ Joseph TalamoChief Financial OfficerMarch 13, 2025Joseph Talamo(principal financial officer) /s/ John WesolowskiPrincipal Accounting Officer and ControllerMarch 13, 2025John Wesolowski(principal accounting officer) /s/ Daniel DonovanDirectorMarch 13, 2025Daniel Donovan  /s/ Dr. Emer LeahyDirectorMarch 13, 2025Dr. Emer Leahy     /s/ Dr. Mark A. GoldbergDirectorMarch 13, 2025Dr. Mark A. Goldberg  /s/ Thomas I. H. DubinDirectorMarch 13, 2025Thomas I. H. Dubin

114